Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
J. H. Pickar, D. F. Archer, S. R. Goldstein, R. Kagan, B. Bernick & S. Mirkin. (2020) Uterine bleeding with hormone therapies in menopausal women: a systematic review. Climacteric 23:6, pages 550-558.
Read now
Read now
Anita L Nelson. (2015) An update on new orally administered contraceptives for women. Expert Opinion on Pharmacotherapy 16:18, pages 2759-2772.
Read now
Read now
Daniela Rouskova, Katrin Mittmann, Ulrike Schumacher, Horst Dietrich & Thomas Zimmermann. (2015) Effectiveness, tolerability and acceptance of a low-dosed estradiol/dienogest formulation (Lafamme 1 mg/2 mg) for the treatment of menopausal complaints: a non-interventional observational study over 6 cycles of 28 days. Gynecological Endocrinology 31:7, pages 560-564.
Read now
Read now
Daniela Rouskova, Katrin Mittmann, Ulrike Schumacher, Horst Dietrich & Thomas Zimmermann. (2014) Effectiveness, tolerability and acceptance of an oral estradiol/levonorgestrel formulation for the treatment of menopausal complaints: a non-interventional observational study over six cycles of 28 days. Gynecological Endocrinology 30:10, pages 712-716.
Read now
Read now
Johannes Bitzer, Susanne Parke, Thomas Roemer & Marco Serrani. (2011) Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest. International Journal of Women's Health 3, pages 127-132.
Read now
Read now
R Sitruk-Ware, F Husmann, JHH Thijssen, SO Skouby, F Fruzzetti, J Hanker, J Huber & R Druckmann. (2004) Role of progestins with partial antiandrogenic effects. Climacteric 7:3, pages 238-254.
Read now
Read now
Articles from other publishers (9)
Ya.Z. Zaidieva & V.D. Kazantseva. (2021) Comparative analysis of the prevalence of abnormal uterine bleeding in postmenopausal women against the background of various menopausal hormone therapy (systematic review). Rossiiskii vestnik akushera-ginekologa 21:6, pages 51.
Crossref
Crossref
Alfred O. Mueck & Thomas Römer. (2019) Choice of progestogen for endometrial protection in combination with transdermal estradiol in menopausal women. Hormone Molecular Biology and Clinical Investigation 37:2.
Crossref
Crossref
Joan Pitkin. (2013) Should HRT be duration limited?. Menopause International 19:4, pages 167-174.
Crossref
Crossref
Selahattin Kumru, Fahrettin M. Yildiz, Ahmet Godekmerdan, Selim Kutlu, Bayram Yilmaz & Bilgin Gurates. (2007) Effects of raloxifene and hormone replacement therapy on serum Th2 and Th3 type cytokine concentrations in healthy postmenopausal women: a randomised controlled trial. Archives of Gynecology and Obstetrics 277:6, pages 489-493.
Crossref
Crossref
Jan Endrikat, Thomas Graeser, Uwe Mellinger, Kubilay Ertan & Cornelia Holz. (2007) A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women. Maturitas 58:2, pages 201-207.
Crossref
Crossref
E. Drapier-Faure, C. Azoulay & Y. Abramovici. (2005) Acceptabilit? par les patientes d'un THS combin? continu versus cyclique?: une ?tude clinique randomis?e multicentrique fran?aise. Gyn?cologie Obst?trique & Fertilit? 33:7-8, pages 498-504.
Crossref
Crossref
Linda Kok, Sanne Kreijkamp-Kaspers, Diederick E. Grobbee, Johanna W. Lampe & Yvonne T. van der Schouw. (2005) A randomized, placebo-controlled trial on the effects of soy protein containing isoflavones on quality of life in postmenopausal women. Menopause 12:1, pages 56-62.
Crossref
Crossref
&NA;. (2002) Estradiol Valerate/Dienogest: profile report. Drugs & Therapy Perspectives 18:6, pages 1-3.
Crossref
Crossref
Keri Wellington & Caroline M. Perry. (2002) Estradiol Valerate/Dienogest. Drugs 62:3, pages 491-504.
Crossref
Crossref